These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38565090)

  • 1. IGFBP5 Promotes Neuronal Apoptosis in a 6-OHDA-Toxicant Model of Parkinson's Disease by Inhibiting the Sonic Hedgehog Signaling Pathway.
    Guo S; Lei Q; Yang Q; Chen R
    Med Princ Pract; 2024; 33(3):269-280. PubMed ID: 38565090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway.
    Ge H; Yan Z; Zhu H; Zhao H
    Exp Mol Pathol; 2019 Aug; 109():16-24. PubMed ID: 31067440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor binding protein 5 (IGFBP5) mediates methamphetamine-induced dopaminergic neuron apoptosis.
    Qiao D; Xu J; Le C; Huang E; Liu C; Qiu P; Lin Z; Xie WB; Wang H
    Toxicol Lett; 2014 Nov; 230(3):444-53. PubMed ID: 25127757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Neuroprotective Role of MiR-124-3p in a 6-Hydroxydopamine-Induced Cell Model of Parkinson's Disease via the Regulation of ANAX5.
    Dong RF; Zhang B; Tai LW; Liu HM; Shi FK; Liu NN
    J Cell Biochem; 2018 Jan; 119(1):269-277. PubMed ID: 28543594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemisinin Confers Neuroprotection against 6-OHDA-Induced Neuronal Injury In Vitro and In Vivo through Activation of the ERK1/2 Pathway.
    Li Q; Li S; Fang J; Yang C; Zhao X; Wang Q; Zhou W; Zheng W
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-Like Growth Factor Binding Protein 2 Drives Neurodegeneration in Parkinson's Disease: Insights From In Vivo and In Vitro Studies.
    An J; Wen L; Yu H; Bu Z; Feng J
    CNS Neurosci Ther; 2024 Oct; 30(10):e70076. PubMed ID: 39412224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of chlorogenic acid: Modulation of Akt/Erk1/2 signaling to prevent neuronal apoptosis in Parkinson's disease.
    He S; Chen Y; Wang H; Li S; Wei Y; Zhang H; Gao Q; Wang F; Zhang R
    Free Radic Biol Med; 2024 Sep; 222():275-287. PubMed ID: 38925315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death.
    Chen G; Bower KA; Ma C; Fang S; Thiele CJ; Luo J
    FASEB J; 2004 Jul; 18(10):1162-4. PubMed ID: 15132987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway.
    Yue P; Gao L; Wang X; Ding X; Teng J
    Neurochem Res; 2017 May; 42(5):1366-1374. PubMed ID: 28247332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fumaria vaillantii extract protects PC12 cells against neurotoxicity induced by 6-OHDA.
    Javid H; Rahimian R; Salimi M; Haghani-Samani E; Farhadi M; Torkaman-Boutorabi A
    Mol Biol Rep; 2024 Jun; 51(1):768. PubMed ID: 38884894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human albumin prevents 6-hydroxydopamine-induced loss of tyrosine hydroxylase in in vitro and in vivo.
    Zhang LJ; Xue YQ; Yang C; Yang WH; Chen L; Zhang QJ; Qu TY; Huang S; Zhao LR; Wang XM; Duan WM
    PLoS One; 2012; 7(7):e41226. PubMed ID: 22815976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tet1-mediated activation of the Ampk signaling by Trpv1 DNA hydroxymethylation exerts neuroprotective effects in a rat model of Parkinson's disease.
    Fan Y; Wang P; Jiang C; Chen J; Zhao M; Liu J
    Funct Integr Genomics; 2024 Sep; 24(5):161. PubMed ID: 39285026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
    Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
    Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the neuroprotective potential of caffeic acid phenethyl ester in a cellular model of Parkinson's disease.
    Turan D; Abdik H; Sahin F; Avşar Abdik E
    Eur J Pharmacol; 2020 Sep; 883():173342. PubMed ID: 32634439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective Effects of Tanshinone I Against 6-OHDA-Induced Oxidative Stress in Cellular and Mouse Model of Parkinson's Disease Through Upregulating Nrf2.
    Jing X; Wei X; Ren M; Wang L; Zhang X; Lou H
    Neurochem Res; 2016 Apr; 41(4):779-86. PubMed ID: 26537816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson's disease.
    Tsuboi K; Shults CW
    Exp Neurol; 2002 Jan; 173(1):95-104. PubMed ID: 11771942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
    Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
    Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonic hedgehog delivered by an adeno-associated virus protects dopaminergic neurones against 6-OHDA toxicity in the rat.
    Dass B; Iravani MM; Huang C; Barsoum J; Engber TM; Galdes A; Jenner P
    J Neural Transm (Vienna); 2005 Jun; 112(6):763-78. PubMed ID: 15586304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.
    Kopalli SR; Noh SJ; Koppula S; Suh YH
    Neurotoxicology; 2013 Jan; 34():25-32. PubMed ID: 23068419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.